Follow
Sarvesh Sabarathinam
Sarvesh Sabarathinam
Assistant Professor, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM IST
Verified email at srmist.edu.in
Title
Cited by
Cited by
Year
Junk food-induced obesity-a growing threat to youngsters during the pandemic
A Singh, D Dhanasekaran, N Ganamurali, L Preethi, S Sabarathinam
Obesity Medicine 26, 100364, 2021
492021
Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect
L Preethi, N Ganamurali, D Dhanasekaran, S Sabarathinam
Obesity Medicine 24, 100346, 2021
352021
Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases
SR SK, PA Anuba, B Swetha, PM Aishwarya, S Sabarathinam
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16 (3), 102451, 2022
292022
Green synthesis of silver nanoparticles from Cassia Auriculata: Targeting antibacterial, antioxidant activity, and evaluation of their possible effects on saltwater …
C Kamaraj, C Ragavendran, K Manimaran, S Sarvesh, ARMT Islam, ...
Science of the Total Environment 861, 160575, 2023
232023
Prevalence and pattern of usage of complementary and alternative medicine among south Indian asthma patients in a tertiary care hospital
S Sarvesh, MKM Raja, MG Rajanandh, P Seenivasan
Complementary Therapies in Clinical Practice 30, 103-108, 2018
172018
Synthesize palladium nanoparticles from the macroalgae Sargassum fusiforme: An eco-friendly tool in the fight against Plasmodium falciparum?
C Kamaraj, C Ragavendran, RCS Kumar, S Sabarathinam, C Vetrivel, ...
Science of The Total Environment 857, 159517, 2023
162023
Synthesis and in vitro studies for structure-based design of novel chalcones as antitubercular agents targeting InhA
SS L S DHIVYA, BR PRADEEPA
FUTURE MEDICINAL CHEMISTRY, 2022
142022
Isomers of guggulsterone in hyperlipidemia
S Sabarathinam, TM Vijayakumar
Obesity medicine 22, 100326, 2021
122021
CYP3A4 mediated pharmacokinetics drug interaction potential of Maha-Yogaraj Gugglu and E, Z guggulsterone
VTM Sarvesh Sabarathinam, Satish Kumar Rajappan Chandra
scientific report, 2021
112021
Network pharmacology based pharmacokinetic assessment and evaluation of the therapeutic potential of catechin derivatives as a potential myostatin inhibitor: A special view on …
SKRCSS Sarvesh Sabarathinam
Natural Product Research, 2023
10*2023
Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: a molecular modelling analysis and in-vitro evidence
LS Dhivya, S Sarvesh
Journal of Biomolecular Structure and Dynamics 41 (12), 5399-5417, 2023
92023
Isolation and In silico Study of Curcumin from Curcuma longa and Its Anti-Diabetic Activity
DLSSS Mariyappan Vaithiyalingam
Applied Biochemistry and Biotechnology 194 (10), 2022
9*2022
A glycemic diet improves the understanding of glycemic control in diabetes patients during their follow-up
S Sabarathinam
Future Science OA, 2023
82023
The role of guggulsterone on the NF-κB pathway in inflammatory bowel disease: preclinical evidence
SKS Priya, A Jha, RC Satish Kumar, S Sabarathinam
Future Science OA 8 (6), FSO803, 2022
82022
Chalcones reloaded: an integration of network pharmacology and molecular docking for type 2 diabetes therapy
NG Sarvesh Sabarathinam
Journal of Biomolecular structure and dynamics, 2023
72023
Bempedoic acid: a nonstatin drug for the management of hypercholesterolemia
A Govindaraju, S Sabarathinam
Health Science Reports 4 (4), 2021
72021
Assessment of herb-drug interactions based on the pharmacokinetic changes of probe drug, midazolam
S Sabarathinam, TM Vijayakumar
Drug Metabolism Letters 14 (1), 5-8, 2021
72021
A narrative review on the impact of processed foods/junk foods/preserved foods: Why special attention is required to prevent metabolic syndrome?
SS Divya Saravanan, Suhana Khatoon B
Obesity Medicine 42, 2023
6*2023
A short exploration of selected sensitive CYP3A4 substrates (Probe Drug)
TMV sarvesh sabarathinam
Drug Metabolism Letters 14 (01), DOI: 10.2174/1872312814666200811110024, 2020
6*2020
RP-hplc method development and validation of midazolam: A cyp3a4 probe drug
S Sabarathinam, TM Vijayakumar
Research Journal of Pharmacy and Technology 13 (8), 3565-3568, 2020
62020
The system can't perform the operation now. Try again later.
Articles 1–20